Healthcare provider profile · identity verified

Naila Ramiz, M.D.

Internal Medicine · HOUSTON, TX · NPI 1609845577

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	518	202
Amlodipine Besylate	Amlodipine Besylate	465	175
Losartan Potassium	Losartan Potassium	393	138
Levothyroxine Sodium	Levothyroxine Sodium	333	95
Metformin Hcl	Metformin Hcl	317	108
Gabapentin	Gabapentin	296	101
Pantoprazole Sodium	Pantoprazole Sodium	295	151
Rosuvastatin Calcium	Rosuvastatin Calcium	217	91
Fluticasone Propionate	Fluticasone Propionate	208	121
Lisinopril	Lisinopril	200	66
Carvedilol	Carvedilol	193	89
Nifedipine Er	Nifedipine	189	76
Furosemide	Furosemide	177	81
Albuterol Sulfate Hfa	Albuterol Sulfate	170	62
Metoprolol Succinate	Metoprolol Succinate	163	60
Alendronate Sodium	Alendronate Sodium	159	58
Azithromycin	Azithromycin	158	119
Omeprazole	Omeprazole	155	48
Tizanidine Hcl	Tizanidine Hcl	152	38
Metoprolol Tartrate	Metoprolol Tartrate	149	63
Ozempic	Semaglutide	149	34
Montelukast Sodium	Montelukast Sodium	146	58
Trazodone Hcl	Trazodone Hcl	142	39
Methylprednisolone	Methylprednisolone	141	105
Clopidogrel	Clopidogrel Bisulfate	134	55
Cefdinir	Cefdinir	131	106
Hydralazine Hcl	Hydralazine Hcl	119	42
Eliquis	Apixaban	100	42
Tamsulosin Hcl	Tamsulosin Hcl	97	52
Meloxicam	Meloxicam	94	46
Allopurinol	Allopurinol	89	33
Nystatin	Nystatin	85	55
Potassium Chloride	Potassium Chloride	83	33
Glimepiride	Glimepiride	81	31
Escitalopram Oxalate	Escitalopram Oxalate	80	30
Vitamin D2	Ergocalciferol (Vitamin D2)	80	39
Prednisone	Prednisone	78	48
Pravastatin Sodium	Pravastatin Sodium	77	26
Hydrochlorothiazide	Hydrochlorothiazide	75	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	56
Jardiance	Empagliflozin	69	19
Duloxetine Hcl	Duloxetine Hcl	68	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	68	19
Famotidine	Famotidine	65	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	17
Memantine Hcl	Memantine Hcl	64	17
Glipizide	Glipizide	61	24
Simvastatin	Simvastatin	61	19
Baclofen	Baclofen	60	19
Sertraline Hcl	Sertraline Hcl	59	23
Spironolactone	Spironolactone	58	25
Atenolol	Atenolol	57	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	21
Fluconazole	Fluconazole	54	41
Bupropion Xl	Bupropion Hcl	52	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	52	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	50	48
Clonidine Hcl	Clonidine Hcl	50	14
Ofloxacin	Ofloxacin	49	43
Buspirone Hcl	Buspirone Hcl	48	14
Tramadol Hcl	Tramadol Hcl	48	34
Trulicity	Dulaglutide	48	13
Levofloxacin	Levofloxacin	46	43
Valsartan	Valsartan	45	20
Ciprofloxacin Hcl	Ciprofloxacin Hcl	44	42
Mirtazapine	Mirtazapine	44	17
Triamcinolone Acetonide	Triamcinolone Acetonide	44	35
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	27
Mupirocin	Mupirocin	42	31
Oxybutynin Chloride	Oxybutynin Chloride	42	13
Ibuprofen	Ibuprofen	40	25
Zolpidem Tartrate	Zolpidem Tartrate	40	11
Ezetimibe	Ezetimibe	39	14
Finasteride	Finasteride	39	16
Sucralfate	Sucralfate	39	20
Amiodarone Hcl	Amiodarone Hcl	38	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	38	suppressed
Januvia	Sitagliptin Phosphate	37	11
Ondansetron Hcl	Ondansetron Hcl	37	24
Quetiapine Fumarate	Quetiapine Fumarate	37	17
Ketoconazole	Ketoconazole	34	13
Pregabalin	Pregabalin	34	14
Amoxicillin	Amoxicillin	32	28
Metronidazole	Metronidazole	32	30
Ondansetron Odt	Ondansetron	32	26
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Alprazolam	Alprazolam	31	suppressed
Farxiga	Dapagliflozin Propanediol	31	14
Pioglitazone Hcl	Pioglitazone Hcl	30	11
Ventolin Hfa	Albuterol Sulfate	30	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	29	15
Xarelto	Rivaroxaban	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	12
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	20
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	25	25
Fenofibrate	Fenofibrate,micronized	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Entresto	Sacubitril/Valsartan	24	15
Acetaminophen-Codeine	Acetaminophen With Codeine	23	17
Enalapril Maleate	Enalapril Maleate	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Mounjaro	Tirzepatide	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Methocarbamol	Methocarbamol	17	12
Lactulose	Lactulose	16	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	15
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Brilinta	Ticagrelor	15	suppressed
Calcitriol	Calcitriol	15	suppressed
Colchicine	Colchicine	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	14
Myrbetriq	Mirabegron	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Lovastatin	Lovastatin	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	12
Propranolol Hcl	Propranolol Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Clonidine	Clonidine	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Anastrozole	Anastrozole	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error